YaSheng Group
HERB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 44.4% | -10.5% | -20.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.7% | 33.9% | 22.7% | 33.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 34.9% | 35.2% | 24.2% | 32.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 32.8% | 33.4% | 18.6% | 32.8% |
| EPS Diluted | 0.012 | 0.009 | 0.005 | 0.012 |
| % Growth | 41.4% | 61.1% | -55% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |